Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine the efficacy and safety of linaclotide
administered to patients with irritable bowel syndrome with constipation (IBS-C).
The primary efficacy parameter is the percentage of patients in each treatment group that
meet the protocol definition for Abdominal Pain and Complete Spontaneous Bowel Movement (APC)
Responder.